Illumina Inc

Type: Company
Name: Illumina Inc
Nationality: United States
Web Address: http://www.illumina.com/
First reported 11 hours ago - Updated 11 hours ago - 1 reports

When Illumina Buys Roche: The Dawning Of The Era Of Diagnostics Dominance

With current technology and resources, a well-funded in vitro diagnostics company can create and pursue a strategy of information gathering and informatics application to create medical knowledge, enabling it to assume the risk and manage certain segments ... [Published Health News Daily - 11 hours ago]
First reported 12 hours ago - Updated 12 hours ago - 1 reports

ILLUMINA : Special Notice - Notice of Intent to Negotiate a Sole Source Blanket Purchase Agreement (BPA)

Notice Type: Special NoticePosted Date: 25-JUL-14Office Address: Department of Agriculture ; Agricultural Research Service ; Eastern Business Service CenterSubject: Notice of Intent to Negotiate a Sole Source Blanket Purchase Agreement (BPA)Classification ... [Published 4 Traders - 12 hours ago]
First reported 14 hours ago - Updated 14 hours ago - 1 reports

Why AMAG Pharmaceuticals (AMAG) Could Be Positioned for a Slump

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security ... [Published Yahoo! Finance - 14 hours ago]
First reported 16 hours ago - Updated 16 hours ago - 1 reports

New Challenges of Next-Gen Sequencing

1. Data StorageYou’ve probably seen the plot of Moore’s Law compared to sequencing throughput. In short, the cost of DNA sequencing has plummeted much faster than the cost of disk storage and CPU. A run on the Illumina HiSeq2000 provides enough capacity ... [Published Genetic Engineering News - 16 hours ago]
First reported Jul 28 2014 - Updated 20 hours ago - 1 reports

Cypher Genomics Inc. Teams With Illumina, Also Names President and COO

San Diego-based Cypher Genomics Inc. announced a co-promotion agreement with Illumina Inc. and the selection of Adam Simpson as president and chief operating officer.Related Biotechnology, Pharmaceutical and Healthcare NewsOriginal Article: NEXT ARTICLE ... [Published BioPortfolio - Jul 28 2014]
First reported Jul 27 2014 - Updated Jul 27 2014 - 1 reports

US Federal Business Opportunity: Department of Health and Human Services: Notice of Intent Reagent Kits and Preparation Kit

Agency: Department of Health and Human ServicesOffice: Centers for Disease Control and Prevention Location: Procurement and Grants Office (Atlanta)Date you need to respond by: 30-July-2014Solicitation Number: 73622 Naics code: 334516 Computer and Electronic ... [Published ITbriefing - Jul 27 2014]
First reported Jul 27 2014 - Updated Jul 27 2014 - 1 reports

Illumina Acquires IVD and Companion Diagnostics Consulting Firm Myraqa

Illumina Inc has acquired Myraqa, a regulatory and quality consulting firm specializing in in vitro diagnostics, with emphasis on companion diagnostics.Led by founder and CEO Mya Thomae, Myraqa focuses on regulatory strategy and application support, including ... [Published Clinical Lab Products - Jul 27 2014]
First reported Jul 26 2014 - Updated Jul 26 2014 - 2 reports

Cypher Genomics Teams With Illumina, Names President and COO

San Diego-based Cypher Genomics Inc. announced a co-promotion agreement with Illumina Inc. and the selection of Adam Simpson as president and chief operating officer.The two companies will jointly offer to pharmaceutical companies, through Illumina’s ... [Published San Diego Business Journal - Jul 26 2014]
First reported Jul 24 2014 - Updated Jul 25 2014 - 3 reports

Illumina (ILMN) Trading Near $161.35 Support Level

Illumina Inc (ILMN) presents a trading opportunity that offers a 5.07% return in just 57 days.A covered call on Illumina at the $170.00 level expiring on Sep. '14 offers an assigned return rate of 5.07% or 32.45% annualized. This trade offers 5.82% downside ... [Published MarketIntelligenceCenter.com - Jul 25 2014]
Entities: Illumina Inc
First reported Jul 24 2014 - Updated Jul 25 2014 - 8 reports

Sidra Medical and Research Center to House Genomics Center

Sidra Medical and Research Center will house the High-Throughput Genomics Center. In a release, the Company noted the facility will provide Qatar and the region access to the latest technology to help advance genetic mapping projects. The facility's early ... [Published Individual.com - Jul 25 2014]
First reported Jul 23 2014 - Updated Jul 24 2014 - 5 reports

Illumina Stock Rating Reaffirmed by Credit Suisse (ILMN)

Illumina (NASDAQ:ILMN)Shares of Illumina (NASDAQ:ILMN) traded down 4.15% on Thursday, hitting $173.15. 1,960,128 shares of the company’s stock traded hands. Illumina has a 52-week low of $72.77 and a 52-week high of $184.49. The stock has a 50-day moving ... [Published American Banking News - Jul 24 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 3 reports

Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2014

Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2 ... [Published Nasdaq - Jul 23 2014]

Quotes

Original Article: NEXT ARTICLE More From BioPortfolio on "Cypher Genomics Inc. Teams With Illumina, Also Names President and COO"
...nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."
...a recap of our user group meeting, the trade channel Bio-IT World reported on their observations of PacBio's commercial progress, concluding that, "The ability to sequence genomes and fragments thousands of base periods long has opened up projects that would be monumentally difficult, and thought impossible with standard next generation sequencing."
"We are pleased to welcome Joel to our Board of Directors," said Norman Schwartz, Bio-Rad President and Chief Executive Officer. "His many years of experience across life science and healthcare and will be a valuable addition to Bio-Rad."

More Content

All (718) | News (448) | Reports (0) | Blogs (250) | Audio/Video (0) | Fact Sheets (0) | Press Releases (19)
sort by: Date | Relevance
Heska (HSKA) Jumps: Stock Adds 5.9% in Session ... [Published Benzinga.com - 4 hours ago]
Great British bioscience pioneers - Professor S... [Published BBSRC - 8 hours ago]
When Illumina Buys Roche: The Dawning Of The Er... [Published Health News Daily - 11 hours ago]
ILLUMINA : Special Notice - Notice of Intent to... [Published 4 Traders - 12 hours ago]
Potential Illumina (ILMN) Trade Has 5.67% Downs... [Published MarketIntelligenceCenter.com - 13 hours ago]
Bio-Rad Laboratories appoints Joel McComb to it... [Published PredictWallStreet - 13 hours ago]
Why AMAG Pharmaceuticals (AMAG) Could Be Positi... [Published Yahoo! Finance - 14 hours ago]
New Challenges of Next-Gen Sequencing [Published Genetic Engineering News - 16 hours ago]
Cypher Genomics Inc. Teams With Illumina, Also ... [Published BioPortfolio - Jul 28 2014]
US Federal Business Opportunity: Department of ... [Published ITbriefing - Jul 27 2014]
Illumina Acquires IVD and Companion Diagnostics... [Published Clinical Lab Products - Jul 27 2014]
US Federal Business Opportunity: Department of ... [Published ITbriefing - Jul 26 2014]
Global Genomics Market : 2014-2018 [Published MarketResearch.com - Jul 26 2014]
Cypher Genomics Teams With Illumina, Names Pres... [Published San Diego Business Journal - Jul 26 2014]
Pacific Biosciences of California's (PACB) CEO ... [Published Seeking Alpha - Jul 26 2014]
Cypher Genomics Signs Deal with Illumina, Expan... [Published Bio-IT World - Jul 26 2014]
Bio Rad Laboratories : -Rad Announces the Appoi... [Published 4 Traders - Jul 25 2014]
US Federal Business Opportunity: Department of ... [Published ITbriefing - Jul 25 2014]
Illumina (ILMN) Trading Near $161.35 Support Level [Published MarketIntelligenceCenter.com - Jul 25 2014]
Sidra Medical and Research Center to House Geno... [Published Individual.com - Jul 25 2014]
Illumina Given New $195.00 Price Target at Leer... [Published American Banking News - Jul 25 2014]
News 7/25/14 [Published HIStalk - Jul 25 2014]
Illumina Q2 Profit Up 30%, Results Beat View, L... [Published E-Forex - Jul 25 2014]
Genomics startup allies with Illumina [Published U-T San Diego - Jul 24 2014]
Illumina Stock Rating Reaffirmed by Credit Suis... [Published American Banking News - Jul 24 2014]
Cypher Genomics’ Analytics Tech Gains Some Cred... [Published BioPortfolio - Jul 24 2014]
Cypher Genomics And Illumina, Inc. Enter Agreem... [Published BioPortfolio - Jul 24 2014]
Global Genomics and Proteomics Analytical Instr... [Published PR Newswire: Health - Jul 24 2014]
Cypher Genomics’ Analytics Tech Gains Some Cred... [Published Xconomy - Jul 24 2014]
Businesses Bailing on San Diego: Required Reading [Published Voice of San Diego - Jul 24 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Potential Illumina (ILMN) Trade Has 5.67% Downs... [Published MarketIntelligenceCenter.com - 13 hours ago]
Friday’s trading in Illumina Inc (ILMN) gives options traders an opportunity for a 11.79% return. By selling the Sep. '14 $170.00 call and buying the Jan. '15 call at the $115.00 level for a net debit of $49.20, traders will book a profit as long as the ...
Illumina (ILMN) Trading Near $161.35 Support Level [Published MarketIntelligenceCenter.com - Jul 25 2014]
Illumina Inc (ILMN) presents a trading opportunity that offers a 5.07% return in just 57 days.A covered call on Illumina at the $170.00 level expiring on Sep. '14 offers an assigned return rate of 5.07% or 32.45% annualized. This trade offers 5.82% downside ...
Global Genomics and Proteomics Analytical Instr... [Published PR Newswire: Health - Jul 24 2014]
DUBLIN, July 24, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Genomics and Proteomics Analytical Instruments Market 2014-2018" report to their offering.http://photos.prnewswire.com/prnh/20130307/600769Genomics is ...
Illumina CEO on genome sequencing technology [Published FOX Business - Video - Jul 24 2014]
Illumina CEO Jay Flatley discusses 2Q earnings and genome sequencing technology. ...
Frontrunning: July 24 [Published Zero Hedge - Jul 24 2014]
EU to weigh extensive sanctions on Russia ( FT ) U.S. lifts flight ban to Israel ( Reuters ) Russia says will cooperate with MH17 probe led by Netherlands ( Reuters ) Norway faces ‘concrete and credible’ terrorist threat ( FT ) Don’t Tell Anybody About ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Global Genomics and Proteomics Analytical Instr... [Published GlobeNewswire: Acquisitions News - Jul 24 2014]
Leadership Appointments, Earnings Conference Ca... [Published Financial Services - Jul 17 2014]
Pre-Market Pulse on Health Care Stocks -- Resea... [Published Financial Services - Jul 10 2014]
Critical Alerts For Illumina, T Rowe Price, Dow... [Published Financial Services - Jul 07 2014]
NDA Submission, Results Release Schedules, FDA ... [Published Financial Services - Jul 04 2014]
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.